Deals
Pfizer-Backed Viatris Eyes Jumbo Bond Sale for Mylan Combination
- New company holding calls about euro and dollar bonds
- Plan comes as renewed virus concerns weigh on credit market
This article is for subscribers only.
Pfizer Inc.-backed Viatris is lining up a potential jumbo bond sale in Europe and the U.S. to help pay for the Viagra maker’s combination with Mylan NV.
The issuer may sell four euro tranches as long as 12 years, and/or dollar bonds maturing in up to 30 years, according to information from a person familiar with the matter, who is not authorized to speak publicly and asked not to be identified. Investor calls start on Monday, the person said.